Could a common mineral slow Parkinson's? small trial hints at possibility
NCT ID NCT06339034
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a low dose of lithium (20 mg/day) can slow disease-related changes in the brain and blood of people with early-stage Parkinson's disease. Twenty participants will receive either lithium or a placebo for a period, and researchers will use MRI scans and blood tests to measure markers of nerve damage and inflammation. The goal is to see if lithium, already used for mood disorders, might be repurposed as a disease-modifying therapy for Parkinson's.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lithium (dietary supplement)
What this could lead to
If successful, this could point toward a way to slow Parkinson's progression using a widely available, low-cost supplement.
What could go wrong
This is a very small, early-phase trial testing biomarkers, not symptoms or long-term outcomes. Lithium can affect thyroid and kidney function, and benefits may not materialize.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UBMD Neurology
Williamsville, New York, 14221, United States